VHCP Co-Investment Holdings III, LLC
CIK 1750761 · last filed 2025-02-14
VHCP Co-Investment Holdings III, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider bought $10.5M of KALV on Feb 14, 2025. Across all open-market trades the lifetime net is +$29.2M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 57 SEC filings were submitted jointly with Nimish P Shah.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TCDA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
23RD FLOOR
NEW YORK, NY 10018
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | 10%+ Owner | 5,278,985 | $27.00 | $142.53M | $10.49M | 1 | 2025-02-14 |
| Tricida, Inc. (TCDA) Delisted | 10%+ Owner | 5,773,654 | $0.11 | $623.6K | $17.49M | 1 | 2022-06-06 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | 10%+ Owner | 483,411 | $0.01 | $5.8K | $1.26M | 1 | 2018-09-17 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-14 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Buy (P) | +1,131,900 | $10.49M | EDGAR |
| 2022-06-06 | Tricida, Inc. (TCDA) Delisted | Buy (P) | +1,908,710 | $17.49M | EDGAR |
| 2018-09-17 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Buy (P) | +1,050,000 | $1.26M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.